PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
| Image |  |
|---|---|
| Description | scientific article published on 30 November 2017 |
| Author/s | |
| Publication date | November 30, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |